Please ensure Javascript is enabled for purposes of website accessibility
Cabot Prime Plus Logo
Cabot Prime Plus

Cabot Prime Plus Week Ending April 1, 2022

Stock Recommendation Tracker

The Stock Recommendation Tracker is a table that features all of the current recommendations in all of our portfolios. It’s a quick way for you to see what stocks are currently in our portfolios and will highlight new additions or any changes to our recommendations over the previous week. We include this table at the bottom of the Weekly Summary, and provide a link here at the top to the Stock Recommendations Tracker.

Cabot Weekly Review (Video)

In this week’s stock market video, Tyler Laundon discusses the improvement in the broad market over the last three weeks, but also notes that Q1 performance is the worst in two years. He goes down the yield curve inversion rabbit hole and shows what the data really says (hint: it’s not all bad). Tyler then tees up healthcare as a sector that should do well in the quarters ahead. He gets into the details of two stocks and tosses out a few more stories that look intriguing now.


Cabot Prime Insider Live Analyst Briefing with Q&A: 2nd Quarter 2022

FREE MEMBER BRIEFING: April 13, 2022 Sign up now.

Cabot Micro-Cap Insider Live Analyst Briefing with Q&A

FREE MEMBER BRIEFING: April 14, 2022 Sign up now.

The New Dawn of Dividends and Value

FREE MEMBER BRIEFING: April 21, 2022 Sign up now.

Cabot Retirement Club Live Analyst Briefing with Q&A

FREE MEMBER BRIEFING: April 28, 2022 Sign up now.

Advisory Services

Cabot Growth Investor

Bi-weekly Update March 31: Stocks had their second straight bad day today to close out the quarter. At day’s end, the Dow had sunk 550 points, the Nasdaq dropped 222 points and many growth stocks got hit hard.

Alert March 29: The market had another solid day today, which was enough to flip our Cabot Tides back to a bullish signal. There are still lots of crosscurrents and news-driven action out there among individual stocks, so we don’t think diving into the market with both feet is the right move, but we are going to put another chunk of money to work tonight by adding half-sized positions in both Palo Alto Networks (PANW) and CarGurus (CARG), leaving us with around 45% in cash.

Bi-weekly Issue March 24: The market’s evidence continues to improve, with more bullish breadcrumbs being dropped–last week, it came via a rare, blastoff-type indicator that triggered for just the fifth time since 1970. To be fair, our primary indicators are still iffy, so you shouldn’t throw caution to the wind, but we’re doing a bit more nibbling tonight, and aim to continue buying if the market can prove itself on the upside going forward.

Cabot Top Ten Trader

Movers & Shakers April 1: This week started off very strongly, especially on Tuesday, when some reports of peace talks overseas caused a big gap up in the indexes and a strong rise across the market. That was enough to flip the intermediate-term trend back to positive for the first time since the start of the year.

Weekly Issue March 28: This week’s list is a mix of strong commodity names and some chip and growth titles that have perked up. Our Top Pick is PDC Energy (PDCE), a small-cap energy name with a recent acquisition that should lead to ridiculous payouts and buybacks going ahead.

Cabot Undervalued Stocks Advisor

Weekly Update March 30: Almost everywhere in the mainstream media and across most Wall Street research firms, there is a common implication that a recession will bring a bear market for stocks.

Monthly Issue March 9: The world has clearly changed in the past two weeks. We see an exceptionally wide range of possible outcomes, which makes predictions about the future (already a low success rate endeavor) basically futile. We offer our timeless investing advice that can be readily applied in such situations.

Cabot Stock of the Week

Weekly Issue March 28: With the market looking increasingly healthy and investors getting increasingly bullish, I’m going to continue to move the portfolio back toward a fully invested position—while keeping it diversified. Tim’s top pick Intel is an icon of the technology revolution. The company makes chips or processors that are essentially the brains of the computer. It is one of the largest semiconductor companies in the world, with $79 billion in annual revenue, and holds by far the largest market share of the PC and server processor markets.

Cabot Explorer

Bi-weekly Issue March 31: Explorer stocks had another good week as markets adapt to the Russia-Ukraine conflict’s impact on commodity markets. Oil prices pulled back a bit following plans to release reserves. This week we look back in history at a global giant in agriculture and food that is backing our new-age recommendation hailing from Montana.

Bi-weekly Update March 24: As NATO leaders meet in Brussels and the Russian stock market opens, the Ukraine-Russia conflict continues to send energy and commodities up. The Euro Stoxx 50 is down 8.7% this year, versus -5.3% for the S&P 500.

Cabot Small-Cap Confidential

Update March 31: There’s been a lot of talk lately about a potential yield curve inversion (happened briefly on Tuesday), so I did some work earlier in the week to see what the data says about small- and large-cap stock performance around inversions.

Monthly Issue March 3: Tyler’s new recommendation Procept BioRobotics (PRCT) is a surgical robotics company specializing in solutions in urology. It invented the AquaBeam Robotic System, an advanced, image-guided, surgical robotic system for use in minimally invasive urologic surgery.

Cabot Dividend Investor

Weekly Update March 30: What a rally off the bottom! After flirting with a severe correction and possibly a bear market, stocks have soared over the past two weeks. The S&P 500 is now down less than 3% YTD. What happened?

Monthly Issue March 9: Value is back. After having been banished for nearly a decade to the mean streets of relative underperformance, a new era is emerging for value stocks. Stocks can be divided into two broad categories, growth and value. Growth stocks are those of companies that are anticipated to grow earnings at a rate significantly above the market or industry averages. These are stocks the tend to increase in value rather than pay a high income.

Cabot Early Opportunities

Alert March 31: Ratings Updates: Sell CNXC and IBM. We’ve enjoyed a nice snap-back rally in the broad market in recent weeks. This has helped us recover some of the “lost” gains in older positions while pumping paper gains in newer ones.

Monthly Issue March 16: The broad market has been going down since the beginning of the year. The S&P 500, Dow, Nasdaq and S&P 600 Small Cap Index are all below both their 50- and 200-day moving average lines. The same can be said for most sector ETFs in both the large- and small-cap asset classes, save areas like energy and utilities. In short, it is a bear market. And in this environment, before we buy any stock we have to ask ourselves – what’s the downside risk?

Cabot Profit Booster

Weekly Issue March 29: Today, I’m adding an American petroleum contract drilling company, Helmerich & Payne, Inc. (HP).

Alert March 18: Despite the market falling dramatically the past month, the Cabot Profit Booster portfolio had a great March expiration cycle as three trades will close for full profits, while one is at a loss.

Cabot Micro-Cap Insider

Weekly Update March 30: The recovery in the stock market (that I touched on last week) has been stunning. The S&P 500 has had an impressive run and is almost back to flat on the year. Sentiment has snapped back but remains slightly negative. This leads me to believe that we could see some additional strength in the market.

Monthly Issue March 9: Rich’s new recommendation Zedge Inc. (ZDGE). The stock has downside protection with significant cash on its balances sheet and no debt. Further, it will grow revenue at least 25% this year and insiders are strongly aligned (they own 19% of the company) to create value. To me, Zedge’s stock price looks completely disconnected from its fundamentals.

Cabot Income Advisor

Weekly Update March 30: We’ve been delivered. In just two short weeks the market has gone from a toxic 2022 market sliding toward bear territory to a huge rally that brings back the hope of a mediocre year. Enjoy the high country.

Monthly Issue March 23: Sure, the rally in the overall market may not last, but this unusual environment is still creating great opportunities in certain pockets if you know where to look. One such opportunity exists in the new and rapidly growing marijuana industry.

Cabot Turnaround Letter

Monthly Issue March 30: All companies are collections of assets. When companies are struggling, a new CEO can redirect how those assets are utilized – a valuable catalyst for a turnaround. We highlight three recent CEO changes and how they might help drive up the value of their companies.

Weekly Update March 25: This week’s Friday Update includes our price target increase for one of our energy companies, as well as updates on several recommended companies. We’re not macro-driven, but we are macro-aware, and are thinking about the reserve status of the U.S. dollar. Also, we bid farewell to Ned Johnson, legendary former CEO of Fidelity.

Alert March 16: We are moving shares of Baker Hughes (BKR) to a Sell. The shares have surged above our previously raised 31 price target (originally 23). Using optimistic yet realistic assumptions, we are hard-pressed to justify a BKR share price meaningfully above the current price.

Cabot Money Club

Monthly Magazine April 1: No matter where you are in your investing journey, this comprehensive list has a saving, spending, or investing app that can help you reach your goals.

Stock of the Month March 18: Clif Droke, Chief Analyst for Cabot’s SX Gold & Metals Advisor, advised me that he had traded out of our latest recommendation, the iPath Series B Bloomberg Tin Subindex Total Return ETN (JJT). But he also noted that he would be looking to trade back into the investment in the near future. This is what Clif had to say:

Cabot ETF Strategist

Weekly Update March 29: As market conditions continue to shift, with large-cap U.S. stocks resuming an uptrend in the past two weeks, we are once again making some changes within the tactical Undiscovered Portfolio. Today, I’m selling two positions and buying two more.

Monthly Issue March 8: The situation with Russia’s invasion of Ukraine has added a fresh bout of volatility to the markets. But U.S. markets, as tracked by the SPDR S&P 500 ETF Trust (SPY), have not plunged far. The SPY fell to an intraday low of 410.64 on February 24 before rallying to finish the session with a gain. The truth is: Stocks were already toying with a correction prior to the Ukrainian situation heating up.

Ask the Experts

Cabot Options Trader

Question: Why did you not pick Alpha and Omega Semiconductor Limited (AOSL) with your Profit Booster recommendation today? It has a better return by far than HP. Risk/reward, it seemed AOSL is a better choice. Can you give me your view?

Jacob:Good question, and really it all came down to keeping the portfolio diversified.In two of the last three weeks, we bought ON Semiconductor (ON) and Pure Storage (PSTG), which are two tech plays, and more loosely semiconductors ... and if I added AOSL, I think that could have been overboard.For that reason, I went away from semiconductors/tech for this week, and added exposure to oil.

Quarterly Cabot Analyst Meeting

The recording of the Cabot Prime Members Meeting with the Analysts from January 12, 2022 is now available for you to listen to at your convenience—click here for access. This private call with our analysts is one of your exclusive Cabot Prime Pro member benefits.